Authors:
Jacobson, JM
Feinman, L
Liebes, L
Ostrow, N
Koslowski, V
Tobia, A
Cabana, BE
Lee, DH
Spritzler, J
Prince, AM
Citation: Jm. Jacobson et al., Pharmacokinetics, safety, and antiviral effects of hypericin, a derivativeof St. John's Wort plant, in patients with chronic hepatitis C virus infection, ANTIM AG CH, 45(2), 2001, pp. 517-524
Authors:
Ng, B
Kramer, E
Liebes, L
Wasserheit, C
Hochster, H
Blank, E
Ceriani, R
Furmanski, P
Citation: B. Ng et al., Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts, CANCER RES, 61(7), 2001, pp. 2996-3001
Authors:
Liebes, L
Conaway, CC
Hochster, H
Mendoza, S
Hecht, SS
Crowell, J
Chung, FL
Citation: L. Liebes et al., High-performance liquid chromatography-based determination of total isothiocyanate levels in human plasma: Application to studies with 2-phenethyl isothiocyanate, ANALYT BIOC, 291(2), 2001, pp. 279-289
Authors:
Prince, AM
Pascual, D
Meruelo, D
Liebes, L
Mazur, Y
Dubovi, E
Mandel, M
Lavie, G
Citation: Am. Prince et al., Strategies for evaluation of enveloped virus inactivation in red cell concentrates using hypericin, PHOTOCHEM P, 71(2), 2000, pp. 188-195
Authors:
Hochster, H
Wadler, S
Runowicz, C
Liebes, L
Cohen, H
Wallach, R
Sorich, J
Taubes, B
Speyer, J
Citation: H. Hochster et al., Activity and pharmacodynamics of 21-day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy, J CL ONCOL, 17(8), 1999, pp. 2553-2561
Authors:
Sparano, JA
Speyer, J
Gradishar, WJ
Liebes, L
Sridhara, R
Mendoza, S
Fry, D
Egorin, MJ
Citation: Ja. Sparano et al., Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer, J CL ONCOL, 17(3), 1999, pp. 880-886
Authors:
Conaway, CC
Jiao, D
Kohri, T
Liebes, L
Chung, FL
Citation: Cc. Conaway et al., Disposition and pharmacokinetics of phenethyl isothiocyanate and 6-phenylhexyl isothiocyanate in F344 rats, DRUG META D, 27(1), 1999, pp. 13-20
Authors:
Gulick, RM
McAuliffe, V
Holden-Wiltse, J
Crumpacker, C
Liebes, L
Stein, DS
Meehan, P
Hussey, S
Forcht, J
Valentine, FT
Citation: Rm. Gulick et al., Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults - AIDS clinical trials group protocols 150 and 258, ANN INT MED, 130(6), 1999, pp. 510-514